Stephen F Martin

This inventor holds 5 USPTO granted patents and 3 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignees: The University of Texas System, Princeton University. Active years: 1976-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Stephen F Martin. Retrieved from https://idiyas.com/inventor/stephen-f-martin

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 5 (Patent Applications = 3)

% Patents Active = 100.0

CIPO Patents = 1 (Patent Applications = 3)

EPO Patents = 1 (Patent Applications = 4)

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 1(Granted Patents)

Company Filing History:

4 out of 5,638

The University of Texas System

Years Active: 1976-2025

Loading Chart...

5 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12325691 - Compounds and methods for treating cancer, neurological disorders, ethanol withdrawal, anxiety, depression, and neuropathic pain (2025-06-10),

2. 11046670 - Piperazinyl norbenzomorphan compounds and methods for using the same (2021-06-29),

3. 10954217 - Sigma receptor binders (2021-03-23),

4. 10450275 - Compounds and methods for treating cancer, neurological disorders, ethanol withdrawal, anxiety, depression, and neuropathic pain (2019-10-22),

5. 3989691 - Preparation of cinchona alkaloid intermediates (1976-11-02),

Title: The Innovative Contributions of Stephen F Martin

Introduction

Stephen F Martin is a notable inventor based in Austin, TX (US), recognized for his significant contributions to the fields of medicine and pharmacology. With a total of 5 patents, Martin has focused on developing compounds and methods that address critical health issues, including cancer and neurological disorders.

Latest Patents

Among his latest patents, Martin has developed compounds and methods for treating cancer, neurological disorders, ethanol withdrawal, anxiety, depression, and neuropathic pain. These innovations provide new avenues for treating diseases that affect millions of people. Additionally, he has disclosed piperazinyl norbenzomorphan compounds and methods for their use, which include treatments for central nervous system diseases, traumatic brain injury, and methods for diagnosing and treating cancer.

Career Highlights

Throughout his career, Martin has been associated with prestigious institutions such as the University of Texas System and Princeton University. His work in these environments has allowed him to collaborate with leading researchers and contribute to groundbreaking advancements in medical science.

Collaborations

Some of his notable coworkers include James J Sahn and Luisa Lynn Scott, who have worked alongside him in various research initiatives. Their combined efforts have furthered the understanding and treatment of complex health conditions.

Conclusion

Stephen F Martin's innovative work and dedication to improving health outcomes through his patents exemplify the impact of research and development in medicine. His contributions continue to inspire future advancements in the field.

Profile summary based on public USPTO records.